Skip to main content

Table 1 Baseline characteristics of participants

From: Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial

 

Intervention - CGM

Control - POCM

(n = 87)

(n = 90)

Age (years)

664 (14.0)

67.2 (11.4)

Women

45 (52%)

35 (39%)

BMI (kg/m2)

27.8 (7.0)

27.4 (5.8)

Weight (kg)

81.8 (21.7)

83.2 (21.5)

History of diabetes*

18 (21%)

21 (23%)

History of renal failure**

10 (12%)

5 (6%)

Reason for ICU admission

  

Surgical

  

 Elective

19 (22%)

16 (18%)

 Emergency

12 (14%)

13 (14%)

Medical

56 (64%)

61 (68%)

Admission diagnosis

  

Post cardiac surgery

12 (14%)

11 (12%)

Severe sepsis/septic shock

23 (26%)

18 (20%)

Pneumonia

12 (14%)

11 (12%)

Cardiac failure

10 (12%)

9 (10%)

COPD

3 (3%)

8 (9%)

Hemorrhagic shock

7 (8%)

10 (11%)

Cardiac arrest/resuscitation

10 (12%)

14(16%)

Other

10 (12%)

9 (10%)

APACHE IV predicted mortality (%)

32 (10-70)

31 (20-60)

SOFA score on admission

8 (6-10)

7 (6-10)

Blood glucose level on admission (mmol/L)

9.0 (2.6)

9.2 (2.5)

Mechanical ventilation

80 (92%)

83 (92%)

  1. Data are mean (SD), median (IQR) or n (%). *Diabetes was defined as present when this diagnosis was mentioned in the medical history; **renal failure was present when the preadmission serum creatinine was above 177umol/l. CGM: continuous glucose monitoring, POCM: point-of-care monitoring, BMI: body mass index, ICU: intensive care unit, SOFA: sequential organ failure assessment, COPD: chronic obstructive pulmonary disease; APACHE: acute physiology and chronic health evaluation.